Overview
Zeinab Afify is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Afify is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. Her top areas of expertise are X-Linked Lymphoproliferative Disease, Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.
Her clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Histiocytosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Additional Areas of Focus
Dr. Afify has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mark Fluchel is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Fluchel is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Non-Langerhans-Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis, Histiocytosis, and Reticulohistiocytoma.
Phillip Barnette is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Barnette is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Leukemia, Hepatoblastoma, and Bone Marrow Aspiration.
Primary Children's Hospital - Hematology Oncology
Dr. Dietz received his degrees in medicine and medical education from the University of New England. He completed his Pediatric Residency and Hematology and Oncology Fellowship at Oregon Health & Science University where he also served as chief resident.In 2020 Dr. Dietz joined the faculty of the University of Utah, where he is currently an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Clinically, Dr. Dietz focuses on the care of pediatric and young adult patients with bone and soft tissue sarcoma, as well as children with retinoblastoma. He is the Associate Director of the Primary Children's Hospital Solid Tumor Program and leads the Comprehensive Retinoblastoma Program. Dr. Dietz is committed to delivering cutting edge clinical care, as well as providing patients with access to experimental therapeutics and discovery programs.�Dr. Dietz's research efforts include team science approaches to better understand the biology driving cancer progression and treatment resistance with a focus on translating this work into new therapies. He is a member of the Huntsman Cancer Institute's Experimental Therapeutics Program and actively involved in the development of early phase clinical trials through multiple cooperative consortia including the Children's Oncology Group, The Sunshine Project, the Pediatric Oncology Experimental Therapeutics Investigator's Consortium, and the Pediatric Early Phase Clinical Trial Network. Dr. Dietz is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Ewing Sarcoma, Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- X-Linked Lymphoproliferative DiseaseDr. Afify isDistinguished. Learn about X-Linked Lymphoproliferative Disease.
- Advanced
- Hemophagocytic Lymphohistiocytosis
- Experienced
- Aase SyndromeDr. Afify isExperienced. Learn about Aase Syndrome.
- Alpha ThalassemiaDr. Afify isExperienced. Learn about Alpha Thalassemia.
- AnemiaDr. Afify isExperienced. Learn about Anemia.
- Classical Hodgkin LymphomaDr. Afify isExperienced. Learn about Classical Hodgkin Lymphoma.
- Diencephalic SyndromeDr. Afify isExperienced. Learn about Diencephalic Syndrome.
- DRESS SyndromeDr. Afify isExperienced. Learn about DRESS Syndrome.